The PE Ratio as of May 2025 (TTM) for Cyclacel Pharmaceuticals, Inc. (CYCCP) is -2.05

According to Cyclacel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.05. This represents a change of -99.81% compared to the average of -1089.91 of the last 4 quarters.

Cyclacel Pharmaceuticals, Inc. (CYCCP) Historical PE Ratio (quarterly & annually)

How has CYCCP PE Ratio performed in the past?

The mean historical PE Ratio of Cyclacel Pharmaceuticals, Inc. over the last ten years is -104.29. The current -2.05 PE Ratio has changed 96.56% with respect to the historical average. Over the past ten years (40 quarters), CYCCP's PE Ratio was at its highest in in the March 2025 quarter at 0. The PE Ratio was at its lowest in in the September 2024 quarter at -4354.99.

Cyclacel Pharmaceuticals, Inc. (CYCCP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cyclacel Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclacel Pharmaceuticals, Inc. (CYCCP) Average PE Ratio

How has CYCCP PE Ratio performed in the past?

The current PE Ratio of Cyclacel Pharmaceuticals, Inc. (CYCCP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cyclacel Pharmaceuticals, Inc. (CYCCP) PE Ratio vs. Peers

How is CYCCP’s PE Ratio compared to its peers?

Cyclacel Pharmaceuticals, Inc.’s PE Ratio is greater than Absci Corporation (-3.13), less than Larimar Therapeutics, Inc. (-1.30), less than InMed Pharmaceuticals Inc. (-0.00), less than Kronos Bio, Inc. (-0.63), greater than OmniAb, Inc. (-2.47), less than Vaxart, Inc. (-1.79), less than Novavax, Inc. (2.39), greater than Ocugen, Inc. (-4.22), less than CohBar, Inc. (-0.10), greater than Rain Enhancement Technologies Holdco Inc (-6.67), less than AVROBIO, Inc. (-0.36), less than Ocean Biomedical, Inc. (-0.01), less than Enveric Biosciences, Inc. (-0.24), less than Elevation Oncology, Inc. (-0.39),

Build a custom stock screener for Cyclacel Pharmaceuticals, Inc. (CYCCP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclacel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclacel Pharmaceuticals, Inc. (CYCCP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclacel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.